1.
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
by O'Donnell, Martin J, Dr
The Lancet (British edition), 2016, Vol.388 (10046), p.761-775
2.
Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million pa...
by YUAN LU
The Lancet (British edition), 2014, Vol.383 (9921), p.970-983
3.
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults
by Sun, Luanluan
Nature medicine, 2019, Vol.25 (4), p.569-574
4.
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
by Di Angelantonio, Emanuele
The Lancet (British edition), 2010, Vol.375 (9709), p.132-140
5.
Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis
by Chaker, Layal
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (6), p.2181-2191
6.
The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis
by Zhang, Jie
Annals of the rheumatic diseases, 2014, Vol.73 (7), p.1301-1308
7.
Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis
by Holmes, Michael V
American journal of human genetics, 2014, Vol.94 (2), p.198-208
8.
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation
by Aulin, Julia, MD
The American heart journal, 2015, Vol.170 (6), p.1151-1160
9.
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials
by Holmes, Michael V, DLSHTM
The Lancet (British edition), 2011, Vol.378 (9791), p.584-594
10.
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke
by Rothwell, Peter M, Prof
The Lancet (British edition), 2011, Vol.377 (9778), p.1681-1692
11.
Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke
by Duan, Xiaomei
Journal of diabetes and its complications, 2014, Vol.28 (5), p.705-710
12.
Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
by Anderson, Jeffrey L., MD
The American journal of cardiology, 2016, Vol.117 (5), p.794-799
13.
A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study
by Durup, Darshana
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (6), p.2339-2346
14.
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
by Thompson, Alexander
The Lancet (British edition), 2010, Vol.375 (9725), p.1536-1544
15.
Observational Study of Obstructive Sleep Apnea in Wake-Up Stroke: The SLEEP TIGHT Study
by Koo, Brian B
Cerebrovascular diseases (Basel, Switzerland), 2016, Vol.41 (5-6), p.233-241
16.
Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis
by Chaker, Layal
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (11), p.4270-4282
17.
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Admi...
by Navarro-Millán, Iris Iris
Annals of the rheumatic diseases, 2015, Vol.75 (2), p.341-347
18.
Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Di...
by Sone, Hirohito
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (11), p.3448-3456
19.
Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronar...
by Tuñón, José, MD, PhD
The American journal of cardiology, 2014, Vol.113 (3), p.434-440
20.
Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target
by Denes, Adam
Cerebrovascular diseases (Basel, Switzerland), 2011, Vol.32 (6), p.517-527
